The Medicine Maker | The Medicine Maker

The Scalability Challenge in MSC Therapies

June 12, 2026

John Yoshi Shyu on why mesenchymal stem cell programs stall – and how early manufacturing decisions can determine clinical and commercial success

4 min read

Cell & Gene

Roving Reporter Asks: What Emerging Approaches Could Define the Next Wave of Advanced Therapies?

IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore the emerging modalities and technologies that could shape the next era of cell and gene therapy

Regulation & Standards

AI in Drug Development: Moving Beyond Early Use Cases

As new rules take hold, what does “good AI practice” look like in drug development?

Biopharma

This Week’s Biopharma News: Big Moves in Bispecifics

Akeso’s PD-1/VEGF bispecific beats PD-1 plus chemo in lung cancer, Amgen wins EC approval for its DLL3-targeted T-cell engager, and Aragen scales Renaissance’s Fast Track anti-GD2 antibody

Cell & Gene

Building the Cell Therapy Ecosystem

Antoinette Gawin discusses leadership, innovation in blood and cell therapy, and the global systems shaping access to advanced medicine

Cell & Gene Small Molecules Biopharma Future of Pharma

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

Our celebration of the most inspirational and influential leaders in medicine.

Find out more

Christine Allen

Professor, University of Toronto; Co-founder and CEO, Intrepid Labs

View Profile

Hanns-Christian Mahler

CEO (Chief Enablement Officer) & Board Member, ten23 health

View Profile

FOYA: Celebrating Innovation in Pharma Facilities

We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.

Read the article

All the latest Medicine Maker articles.

Cell & Gene Industry News Research News

This Week’s CGT News: Promising Data for In Vivo CAR T

June 8, 2026

Legend and Kelonia reveal 100 percent response rates in phase 1 trials, dual CAR T opens doors for kidney transplant patients, and iPDSC therapy beefs up failing hearts

5 min read

Biopharma Development & Clinical Outsourcing Business & Trends

Earendil: A Blueprint for a Multipolar Life Sciences Era

June 5, 2026

The $787M financing points to a new global architecture in biotech

5 min read

Cell & Gene Business & Trends

Roving Reporter Asks: How Is Shifting Investment Reshaping Advanced Therapies?

June 4, 2026

IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore how a tougher funding environment is sharpening focus on scalability, cost-efficiency, partnerships, and commercialization in advanced therapies

1 min read

Biopharma Interviews Drug Discovery Development & Clinical

HTC-19 Profile: What’s Cooking in the mRNA Lab?

June 3, 2026

Jonathan Maurer of the University of Geneva discusses his work with Sanofi and Waters – and why good analytical science has a lot in common with good cooking

3 min read

Small Molecules Small Molecules Development & Clinical Interviews

The Case for Simulating Pregnancy

June 2, 2026

Why drug trials exclude pregnant women – and how simulation could change that

7 min read

Biopharma Biopharma Industry News Research News Sponsored

This Week’s Biopharma News: New Approvals, Appeals, and AI

June 2, 2026

Datroway and Hepcludex secure notable FDA approvals, while Outlook wins its bevacizumab appeal, BioMarin reports phase 3 VOXZOGO data, and BMS partners with Anthropic

6 min read

Biopharma Technology & Manufacturing

The New Reality of Peptide Analysis

June 1, 2026

Kelly Broster of Thermo Fisher Scientific explains why GLP-1 peptides are exposing the limits of traditional analytical workflows

12 min read

Cell & Gene Industry News Research News

This Week’s CGT News: Base Editing Takes Aim at Cholesterol

June 1, 2026

Verve reports phase 1 data for one-time PCSK9 base editing; plus: neuroprotective gene therapy, non-viral DNA delivery, tumour-activated CAR-T, and in vivo CAR-M

3 min read

Biopharma Development & Clinical Business & Trends Business Practice

Reimagining Risk and Resilience

May 29, 2026

Accelerating analytical data management for the next-generation laboratory

7 min read

Cell & Gene Technology & Manufacturing

Roving Reporter Asks: Where Is Real Progress Being Made in Manufacturing and Supply Chain?

May 28, 2026

IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore how automation, AI, closed systems, and smarter supply chain models are helping advanced therapies move toward scalable delivery

Top Stories